Proton pump inhibitor co-therapy in patients receiving non-vitamin K antagonist oral anticoagulants: current evidence, gastrointestinal bleeding prevention, and clinical considerations

BackgroundNon-vitamin K antagonist oral anticoagulants (NOACs) are widely prescribed for stroke prevention in atrial fibrillation (AF). Although they reduce intracranial hemorrhage compared with warfarin, gastrointestinal bleeding (GIB), particularly upper GIB (UGIB), remains a clinically significan...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Dong-Hyeok Kim, Yeji Kim, Moon-Hyun Kim, Jeongmin Kang, Junbeom Park
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Frontiers Media S.A. 2026-06-01
سلاسل:	Frontiers in Cardiovascular Medicine
الموضوعات:	atrial fibrillation (AF) gastroprotection non-vitamin K antagonist oral anticoagulants (NOAC) pharmacoepidemiology proton pump inhibitors (PPI) upper gastrointestinal bleeding (UGIB)
الوصول للمادة أونلاين:	https://www.frontiersin.org/articles/10.3389/fcvm.2026.1816099/full
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!